Talia Golan, MD, Head of Sheba Pancreatic Cancer Center explains the potential of the POLO trial maintenance with olaparib in metastatic pancreatic cancer.
The Practice Changing Potential of the POLO Trial
Talia Golan, MD, Head of Sheba Pancreatic Cancer Center explains the potential of the POLO trial maintenance with olaparib in metastatic pancreatic cancer.